Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Métodos Terapéuticos y Terapias MTCI
Bases de datos
Tipo del documento
Intervalo de año de publicación
1.
Rev Med Chir Soc Med Nat Iasi ; 117(2): 525-31, 2013.
Artículo en Inglés | MEDLINE | ID: mdl-24340541

RESUMEN

AIM: To present the research results concerning enhanced antimicrobial and release properties of the chitosan derivative with sulfadiazine/hyaluronic acid polyelectrolyte complex (PEC) hydrogel. MATERIAL AND METHODS: The PECs have been prepared from chitosan of different molecular weight, sulfadiazine chitosan derivative and sodium hyaluronate. The complex structure was assessed by FT-IR spectroscopic method and swelling capacity was followed by weighing measurements. RESULTS: It has been establish that chitosan derivative influenced both PEC properties and swelling capacity. CONCLUSIONS: Incorporation in PEC of the sulfadiazine chitosan is a new way to combine bacteriostatic effect of chitosan with that of sulfadiazine, to control properties, antimicrobial activity in the treatment of the wound.


Asunto(s)
Antiinfecciosos/farmacología , Materiales Biocompatibles/farmacología , Quitosano/farmacología , Ácido Hialurónico/farmacología , Sulfadiazina/farmacología , Viscosuplementos/farmacología , Cicatrización de Heridas/efectos de los fármacos , Antiinfecciosos/síntesis química , Antiinfecciosos/química , Vendajes , Materiales Biocompatibles/síntesis química , Materiales Biocompatibles/química , Quitosano/síntesis química , Quitosano/química , Quimioterapia Combinada/métodos , Electrólitos/química , Ácido Hialurónico/síntesis química , Ácido Hialurónico/química , Espectrofotometría Infrarroja/métodos , Sulfadiazina/síntesis química , Sulfadiazina/química , Viscosuplementos/síntesis química , Viscosuplementos/química
2.
J Pharm Pharmacol ; 47(6): 503-9, 1995 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-7674134

RESUMEN

Two new zinc sulphadiazine (Zn(SD)2)-amine complexes, zinc sulphadiazine-methylamine (Zn(SD)2(CH3NH2)2) and zinc sulphadiazine-ethylenediamine (Zn(SD)2(C2H8N2)3.H2O), were prepared and compared with silver sulphadiazine (AgSD). The compounds were readily obtained by reaction of zinc nitrate hexahydrate with sulphadiazine or its salt in methylamine and ethylenediamine, respectively. Structure was established by X-ray crystallography and ultraviolet-visible, infrared and nuclear magnetic resonance spectroscopy. The products were effective, in-vitro, against Gram-positive and Gram-negative bacteria as well as fungus. However, their activity is partially reversed by p-aminobenzoic acid. Further investigations in burned mice revealed that these compounds displayed a potential value in the prevention and treatment of wound healing, and diminution of mortality and weight loss. The toxicity of Zn(SD)2 derivatives was much lower than that of AgSD. The better aqueous solubility and skin permeability may explain the reason for their superiority over AgSD in the efficacy for topical therapy. Zn(SD)2(CH3NH2)2 was consistently more potent and was chosen for further development in clinical uses. The similarity in complexation between Zn(SD)2(CH3NH2)2 and AgSD may be significant to distinguish that from any other Zn(SD)2 derivative in bioactivity.


Asunto(s)
Quemaduras/tratamiento farmacológico , Sulfadiazina de Plata/uso terapéutico , Sulfadiazina/uso terapéutico , Zinc/uso terapéutico , Animales , Bacterias/efectos de los fármacos , Fenómenos Químicos , Química Física , Cristalografía por Rayos X , Masculino , Ratones , Pruebas de Sensibilidad Microbiana , Permeabilidad , Infecciones por Pseudomonas/prevención & control , Ratas , Ratas Sprague-Dawley , Sulfadiazina de Plata/farmacología , Sulfadiazina/química , Sulfadiazina/farmacología , Aumento de Peso/efectos de los fármacos , Infección de Heridas/prevención & control , Zinc/química , Zinc/farmacología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA